Alzheimer Disease
Blood test shows promise for early diagnosis of Alzheimers disease: According to new study published in the Journal of Alzheimers Disease
Published in Mental Health Business Week, November 21st, 2009
Elderly people exhibiting memory disturbances that do not affect their normal, daily life suffer from a condition called "mild cognitive impairment" (MCI). Some MCI patients go on to develop Alzheimer's disease within a few years, whereas other cases remain stable, exhibiting only benign senile forgetfulness. It is crucial to develop simple, blood-based tests enabling early identification of these patients that will progress in order to begin therapy as soon as possible, potentially delaying the onset of dementia.
A group of investigators, led by Professor Massimo Tabaton of the University of Genoa, Italy, have data that sheds light on this issue. The results of their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Aaron’s Bridge
Autism Nonprofit to Benefit from Sale of State-Based Exchange-Traded Funds - Activision Publishing, Inc.
Activision Partners With Leading Mental Health and Media Researcher Dr. Cheryl Olson on 'Ratings Are Not a Game' Education Initiative - Addiction Medicine
Care Management Technologies Launches Opioid Prescription Intervention Program - AgeSong
"Conversations with Ed" Offers First-Person Insight on Life with Alzheimer's - AllTranz, Inc.
AllTranz Awarded $4 Million Research Grant by NIH and NIDA - Alzheimer Disease
Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease: New 12-Month Study Broadens Phase 3 Clinical Program To Further Evaluate the Benefits of Dimebon In Alzheimers Disease - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
